[The therapeutic effect of kavain and magnesium orotate on traumatic and vascular brain lesions].
D000328:Adult; D000367:Age Factors; D001930:Brain Injuries / Q000188:drug therapy*; D001932:Brain Neoplasms / Q000601:surgery; D002214:Capsules; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003704:Dementia / Q000188:drug therapy; D004149:Dioxoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D009963:Orotic Acid / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy; D012737:Sex Factors; D013997:Time Factors
D002214:Capsules; D004149:Dioxoles; D007783:Lactones; D009963:Orotic Acid; D008274:Magnesium
Der therapeutische Einfluss von Kavain und Magnesium-Orotat auf traumatisch- und gefässbedingte Hirnschäden.